AKERNA CORP (KERN) Fundamental Analysis & Valuation

NASDAQ:KERN • US00973W3007

Current stock price

0.3136 USD
+0.08 (+36.94%)
At close:
0.364 USD
+0.05 (+16.07%)
After Hours:

This KERN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. KERN Profitability Analysis

1.1 Basic Checks

  • In the past year KERN has reported negative net income.
  • KERN had a negative operating cash flow in the past year.
KERN Yearly Net Income VS EBIT VS OCF VS FCFKERN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 -20M -40M -60M -80M

1.2 Ratios

  • With a Return On Assets value of -821.29%, KERN is not doing good in the industry: 98.92% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -821.29%
ROE N/A
ROIC N/A
ROA(3y)-156.88%
ROA(5y)-120.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KERN Yearly ROA, ROE, ROICKERN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 0 500 1K 1.5K

1.3 Margins

  • KERN has a worse Gross Margin (56.92%) than 61.37% of its industry peers.
  • KERN's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for KERN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.77%
GM growth 5Y-4.94%
KERN Yearly Profit, Operating, Gross MarginsKERN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 0 -200 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. KERN Health Analysis

2.1 Basic Checks

  • KERN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, KERN has more shares outstanding
  • KERN has a worse debt/assets ratio than last year.
KERN Yearly Shares OutstandingKERN Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 1M 2M 3M 4M
KERN Yearly Total Debt VS Total AssetsKERN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of -66.44, we must say that KERN is in the distress zone and has some risk of bankruptcy.
  • KERN has a Altman-Z score of -66.44. This is amonst the worse of the industry: KERN underperforms 97.11% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -66.44
ROIC/WACCN/A
WACC3.75%
KERN Yearly LT Debt VS Equity VS FCFKERN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 20M 40M

2.3 Liquidity

  • KERN has a Current Ratio of 0.10. This is a bad value and indicates that KERN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • KERN has a worse Current ratio (0.10) than 98.56% of its industry peers.
  • A Quick Ratio of 0.10 indicates that KERN may have some problems paying its short term obligations.
  • KERN has a worse Quick ratio (0.10) than 98.56% of its industry peers.
Industry RankSector Rank
Current Ratio 0.1
Quick Ratio 0.1
KERN Yearly Current Assets VS Current LiabilitesKERN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. KERN Growth Analysis

3.1 Past

  • KERN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 83.46%, which is quite impressive.
  • KERN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.66%.
  • The Revenue has been growing by 19.51% on average over the past years. This is quite good.
EPS 1Y (TTM)83.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.47%
Revenue 1Y (TTM)-31.66%
Revenue growth 3Y8.05%
Revenue growth 5Y19.51%
Sales Q2Q%-32.03%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y95.9%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-57.91%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KERN Yearly Revenue VS EstimatesKERN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
KERN Yearly EPS VS EstimatesKERN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

0

4. KERN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for KERN. In the last year negative earnings were reported.
  • Also next year KERN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KERN Price Earnings VS Forward Price EarningsKERN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KERN Per share dataKERN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. KERN Dividend Analysis

5.1 Amount

  • No dividends for KERN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

KERN Fundamentals: All Metrics, Ratios and Statistics

AKERNA CORP

NASDAQ:KERN (2/8/2024, 8:00:03 PM)

After market: 0.364 +0.05 (+16.07%)

0.3136

+0.08 (+36.94%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-13
Earnings (Next)03-19
Inst Owners0.7%
Inst Owner Change0%
Ins Owners40.64%
Ins Owner Change0%
Market Cap3.25M
Revenue(TTM)9.82M
Net Income(TTM)-34.33M
Analysts43.33
Price Target0.82 (161.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.14%
Min EPS beat(2)-59.31%
Max EPS beat(2)27.04%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.32%
Min Revenue beat(2)-15.72%
Max Revenue beat(2)-14.93%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.33
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-37.79
EYN/A
EPS(NY)-1.55
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.55
OCFYN/A
SpS0.95
BVpS-0.89
TBVpS-1.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -821.29%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.92%
FCFM N/A
ROA(3y)-156.88%
ROA(5y)-120.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.77%
GM growth 5Y-4.94%
F-Score3
Asset Turnover2.35
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 41.04%
Cap/Sales 10.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.1
Quick Ratio 0.1
Altman-Z -66.44
F-Score3
WACC3.75%
ROIC/WACCN/A
Cap/Depr(3y)132.74%
Cap/Depr(5y)N/A
Cap/Sales(3y)29.68%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.47%
EPS Next Y95.9%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.66%
Revenue growth 3Y8.05%
Revenue growth 5Y19.51%
Sales Q2Q%-32.03%
Revenue Next Year-57.91%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year93.71%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.1%
OCF growth 3YN/A
OCF growth 5YN/A

AKERNA CORP / KERN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AKERNA CORP?

ChartMill assigns a fundamental rating of 0 / 10 to KERN.


What is the valuation status of AKERNA CORP (KERN) stock?

ChartMill assigns a valuation rating of 0 / 10 to AKERNA CORP (KERN). This can be considered as Overvalued.


How profitable is AKERNA CORP (KERN) stock?

AKERNA CORP (KERN) has a profitability rating of 0 / 10.


What is the financial health of AKERNA CORP (KERN) stock?

The financial health rating of AKERNA CORP (KERN) is 0 / 10.